Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Jun 25.
Published in final edited form as: Tetrahedron. 2007 Jul 2;63(27):6141–6145. doi: 10.1016/j.tet.2007.03.034

The azido acid approach to β-peptides: parallel synthesis of a tri-β-peptide library by fluorous tagging

Xiao Wang 1, Scott G Nelson 1, Dennis P Curran 1,*
PMCID: PMC2701693  NIHMSID: NIHMS25206  PMID: 19562094

Abstract

A small tri-β-peptide library was prepared starting from three enantio- and diastereopure azido acids. Fluorous tagging followed by two cycles of azide reduction, fluorous solid phase extraction (f-SPE), peptide coupling with the original azido acids and f-SPE provided 27 protected azido peptides. Reduction and HPLC purification provided 25 of the 27 targeted tri-β-peptides in acceptable yields and excellent purities.

1. Introduction

Oligomers and polymers of β-amino acids, called β-peptides, are of increasing interest because of their structures, folding patterns and potential biological activities.1 Most syntheses of β-peptides are patterned after the traditional approach to making α-peptides.2 The key building blocks are N-protected β-amino acids, which are joined by an iterative sequence of N-deprotection and amide coupling (Figure 1).

Figure 1.

Figure 1

The “amino acid” and “azido acid” approaches to β-peptides

Nelson and coworkers recently introduced an approach to β-peptides that starts from β-azido acids rather than β-amino acids and involves an iterative sequence of reduction of the azide to an amine followed by union of the amine with the next β-azido acid by amide bond formation.3 α-Peptides have also been made from α-azido acids.4 But the azide approach is not used very often because α-amino acids are much more readily available than α-azido acids and because α-azido acid derivatives activated for peptide coupling reactions are prone to racemization. This is unfortunate because atom economy and small size make the azide group attractive compared to protected amines.

For the β-peptide series, enantiopure β-azido acids are readily available by several routes,5 and activated β-azido acids for peptide coupling cannot epimerize at the azide-bearing carbon. Thus, the azide approach merits serious consideration as a general approach to β-peptides.

Only a handful of di-β-peptides and a lone tri-β-peptide have been made by the azide approach to date.3 We set out to extend the scope of the method by making a 27-member library of tri-β-peptides in a 3 × 3 × 3 matrix starting from three enantiopure β-azido acids. To expedite the library preparation, we used a light fluorous tag6,7 on the C-terminus of the first β-azido acid so that intermediates could be quickly purified by fluorous SPE (f-SPE).8 We describe herein the results of this study.

2. Results and Discussion

The syntheses and fluorous tagging of the three β-azido acid building blocks are summarized in Scheme 1. β-Lactones 1a–c are readily made in one step, on multi-gram scale, in >90% ee by the cinchona-alkaloid catalyzed cyclocondensation reactions between acyl halides and aldehydes (AAC reaction).3 Reactions of purified β-lactones 1a,b and with NaN3 in DMF at 50 °C provided β-azido acids 2a,b in quantitative yield. Due to its volatility, β-lactone 1c was not purified; instead, the crude product of the AAC reaction was directly subjected to azide opening, and then the azide was purified. This provided 2c in 65% yield over the two steps. To complete the precursor synthesis, the three β-azido acids (110–140 mg) were esterified with 1.2 equiv of the fluorous PMB alcohol 3 (FPMB-OH)9 in presence of 1-ethyl-3-(3′-dimethylaminopropyl) carbodiimide (EDCI) and N,N-dimethylaminopyridine (DMAP) to obtain the three azido-esters 4ac. These key precursors were purified by standard flash chromatography.

Scheme 1.

Scheme 1

Synthesis of azido acid precursors

The synthesis of the tri-β-peptide library is summarized in Scheme 2 and involves two cycles of azide reduction and amide coupling (45 and 56), followed by a final hydrogenation/hydrogenolysis (67) to reduce the terminal azide and remove the fluorous PMB group.

Scheme 2.

Scheme 2

Synthesis of the tri-β-peptide library

The azides were reduced by a Staudinger procedure.10,11 The three azido-esters 4a–c were treated with 1.2 equiv of triphenylphosphine in THF under microwave irradiation at 120 °C, 250 W. After 5 min, 31P NMR spectroscopic analysis showed complete conversion to the azaylide (see Supplementary Material). Water (20 equiv) was added and the mixtures were again irradiated in the microwave instrument at 120 °C, 250 W. After 10 min, 31P NMR analysis showed disappearance of the azaylide with formation of triphenylphosphine oxide. The samples were concentrated, taken up in a small amount of acetonitrile and loaded onto a fluorous SPE column.9 First pass elution with 70/30 acetonitrile water provided an organic fraction containing triphenylphosphine oxide and unreacted triphenylphosphine, which was discarded. Second pass elution with THF provided the derived amines.

Without further characterization, each of the three intermediate amines was divided into three equal fractions, which were coupled in parallel with each of the three azido acids 2a–c (1.2 equiv). Couplings were effected in dichloromethane with EDCI (1.2 equiv) and DMAP (0.5 equiv). EDCI was chosen because both it and its derived urea are relatively polar and elute very quickly under the first pass conditions of the fluorous solid phase extraction. The progress of the nine reactions was followed by tlc, and after about 30 min, the solvent was removed and the crude products were subjected to f-SPE as above. Again the first pass fraction was discarded and the second pass fraction (THF) was concentrated to provide the nine coupled azido β-peptides 5aa5cc, whose complete structures are shown in Figure 2. Yields of these crude products ranged from 55–86% over the two steps, and they all exhibited satisfactory 1H and 13C NMR spectra. Analyses by LCMS also showed the expected molecular weights (see Supplementary Material).

Figure 2.

Figure 2

Structures of the nine dipeptide azides 5

The nine products 5 were then subjected to a second cycle without further purification. First, reduction with triphenylphosphine and f-SPE provided nine amino di-β-peptides (80–100%). These were each divided into three equal portions followed by coupling with the three azido acids 2a–c as above. Evaporation of the THF fraction following f-SPE provided the 27 azido tri-β-peptides 6aaa6ccc in the yields recorded in Table 1. Also shown in Table 1 is one representative structure (6abc); the full complement of structures are in the Supplementary Material. LCMS analysis of all 27 samples showed the expected molecular weights for the products 6, whose purities were typically 90% or better. Five of the samples selected by molecular weight (including highest, median, lowest) where also analyzed by 1H and 13C NMR to provide additional support for structure and purity.

Table 1.

Yields and MS data for protected azides 6 and final tri-β-peptides 7

graphic file with name nihms25206f5.jpg
entry % 6 MS 6 (calc/obs)a % 7 fspeb % 7 hplcc MS 7 (calc/obs)a
aaa 33 1177.4/1178.2 92 d 585.4/586.3
aab 37 1149.4/1150.0 89 d 557.3/558.3
aac 55 1129.4/1130.2 80 76 537.4/538.3
aba 100 1149.4/1150.2 84 94 557.3/558.3
abb 99 1121.3/1122.0 71 d 529.3/530.2
abc 94 1101.4/1102.2 64 45 509.3/510.3
aca 58 1129.4/1130.2 61 80 537.4/538.3
acb 74 1101.4/1102.2 72 67 509.3/510.2
acc 41 1081.4/1082.2 68 d 489.4/490.4
baa 95 1149.4/1150.0 80 84 557.3/558.3
bab 84 1121.3/1122.2 70 94 529.3/530.2
bac 97 1101.4/1102.2 97 93 509.3/510.2
bba 84 1121.3/1122.2 51 99 529.3/530.2
bbb 87 1093.3/1094.2 60 d 501.3/502.2
bbc 75 1073.3/1074.2 88 86 481.3/482.2
bca 30 1101.4/1102.2 82 64 509.3/537.3e
bcb 46 1073.3/1074.2 76 53 481.3/482.3
bcc 41 1053.4/1054.2 79 87 461.3/462.3
caa 42 1129.4/1130.2 87 91 537.4/538.3
cab 53 1101.4/1102.2 71 75 509.3/510.4
cac 69 1081.4/1082.2 55 78 489.4/490.3
cba 97 1101.4/1102.2 69 71 509.3/510.2
cbb 92 1073.3/1074.2 88 90 481.3/482.2
cbc 88 1053.4/1054.2 88 57 461.3/462.3
cca 37 1081.4/1082.2 82 40 489.4/490.4
ccb 38 1053.4/1054.2 97 83 461.3/469.2e
ccc 33 1033.4/1034.2 78 88 441.4/442.4
a

m/z for M + 1 ion;

b

yield 7 after fluorous solid phase extraction;

c

recovery of 7 after hplc purification;

d

the product after f-SPE was pure by HPLC analysis and was not further purified;

e

the mass spectrum is not consistent with the target product (see text).

Finally, the terminal azides 6 were reduced and the FPMB groups were removed simultaneously by reduction with hydrogen in t-butanol catalyzed by palladium hydroxide. Three initial reactions were conducted in vials and the crude products processed by f-SPE in cartridges as above to remove both the catalyst and the residual fluorous tag. This time, the first pass fraction was concentrated and the second pass fraction was discarded. The remaining 24 samples were then hydrogenated together in a 24-well parallel synthesizer, followed by plate-to-plate solid phase extraction12 and concentration.

After a preliminary analysis by LCMS (reverse phase conditions), most of the crude tri-β-peptides 7 were purified by serial reverse phase HPLC under a standard set of conditions to provide purified products in the yields indicated in Table 1 (see Supplementary Material for all structures). These zwitterionic products are generally white powders that were sparingly soluble in most organic solvents tested. They were then reanalyzed by LCMS to confirm identity and purity. Twenty-five of the products exhibited essentially a single peak with the expected mass. Several of these products were again checked by 1H NMR analysis (D2O/CD3CN) to confirm structure and purity (see Supplementary Material).

Two of the products do not appear to have the expected structures based on MS analysis. The product 7bca exhibited peaks for (M – H2O + Na) and (M – H2O + 2Na), suggesting that it might be a dehydrated cyclic peptide. The MS for 7ccb suggests that this product results from reductive deamination (hydrogenolysis) of the terminal benzylic amino group. These side reactions seem to be sequence specific, since they were not observed for any other members of the library.

3. Summary and Conclusions

In summary, we have parlayed three readily available azido acids 2a–c into a small library of tri-β-peptides 7 in amino acid form by fluorous tagging, two cycles of azide reduction and peptide coupling, and detagging with concomitant azide reduction. To expedite the synthesis, intermediates were purified only by fluorous solid phase extraction; however, the final products were purified by preparative hplc to ensure good quality. This approach provided 25 of the 27 library members in acceptable yields and excellent purities.

The results suggest that the azido acid approach to making β-peptide oligomers deserves serious consideration as an alternative to the more traditional amino acid approach. The usefulness of the new approach will grow as a function of the availability of isomerically pure azido acids. The results further show the generality of fluorous solid phase extraction, whether in cartridges or in plate-to-plate format, as a method for rapid yet effective purification of molecules bearing light fluorous tags.

4. Experimental

General procedure 1: SN2 addition of NaN3 to β-lactones.3,5a

The β-lactone (6.0 mmol) was added via syringe to a solution of NaN3 (12.0 mmol) in anhydrous DMF (35 mL, 0.3 M in lactone) at 50 °C. The resulting homogeneous solution was stirred for 4–5 h. The reaction mixture was cooled to ambient temperature (25 °C), and saturated aqueous NaHCO3 (30 mL) was added. The resulting heterogeneous mixture was diluted with water until all the precipitated salts dissolved. The resulting mixture was washed with ethyl acetate (2 × 50 mL) and the aqueous layer was acidified with 1 M aqueous HCl to pH ≈ 1. The acidic aqueous layer was extracted with ethyl acetate (3 × 50 mL) and the combined organic portions were washed with water (2 × 50 mL) and brine (2 × 50 mL). The organic portion was dried (Na2SO4) and evaporated in vacuo to afford the β-azido acid.

General procedure 2: FPMB tagging

To a solution of β-azido acid (0.2 mmol) in CH2Cl2 (10 mL) was added N,N-dimethylaminopyridine (DMAP) (12 mg, 0.10 mmol). With stirring, FPMB-OH (16, 140 mg, 0.240 mmol) was added to the solution followed by 1-ethyl-3-(3′-dimethylaminopropyl) carbodiimide (EDCI) (46 mg, 0.24 mmol). After 30 min, the mixture was partitioned between Et2O (30 mL) and 1M aqueous HCl (15 mL). The organic layer was separated and washed with H2O (10 mL) and brine (10 mL), then dried with Na2SO4 and evaporated in vacuo to afford the crude FPMB ester. This was purified by flash chromatography (4:1 Hex:EtOAc).

General procedure 3: Staudinger reaction.10

In a microwave tube, the azido ester or the azido β-peptide (0.2 mmol) was dissolved in dry THF (0.5 mL). A solution of triphenylphosphine (63 mg, 0.24 mmol) in dry THF (1 mL) was added into the microwave tube by syringe. The mixture was heated in the microwave reactor under stirring at 120 °C, 250 W, for 5 min. H2O (72 mg, 4.0 mmol) was added to the microwave tube via syringe. The resulting mixture was microwaved for 10 min, at 120 °C, 250 W. The reaction progress can be monitored by 31P NMR if desired (31P NMR spectra were recorded at 121.5 MHz. THF-d8 was used as solvent. For calibration, the chemical shift of triphenylphosphine was set at −4.80 ppm. The chemical shifts of triphenylphosphine oxide and phosphorus ylide are around 24 ppm and 1 ppm, respectively.).13 The solvent was removed in vacuo. A new f-SPE cartridge (5 g) was washed with THF (20 mL) under a vacuum on the SPE manifo ld and preconditioned by passing through 70:30 MeCN:H2O (30 mL). The crude product was dissolved in MeCN (1 mL) and loaded onto the cartridge using vacuum to ensure that the sample was completely adsorbed onto the silica. The cartridge was washed with 70:30 MeCN:H2O (50 mL) to obtain the fraction containing the organic compounds, and washed with THF (30 mL) to obtain the fraction containing the fluorous compounds. The fluorous fraction was dried with Na2SO4 and the solvent was evaporated in vacuo to afford the amine.

General procedure 4: amide coupling

DMAP (12 mg, 0.10 mmol) was added to a solution of amine (0.2 mmol) in CH2Cl2 (2 mL). With stirring, β-azido acid (0.24 mmol) was added to the solution, followed by adding EDCI (46 mg, 0.24 mmol) and CH2Cl2 (1 mL). The mixture was stirred for 30 min, and then the solvent was removed in vacuo. A new f-SPE cartridge (5 g) was washed with THF (20 mL) under a vacuum on the SPE manifold and preconditioned by passing through 70:30 MeCN:H2O (30 mL). The crude product was dissolved in MeCN (1 mL) and loaded onto the cartridge using vacuum to ensure that the sample was completely adsorbed onto the silica. The cartridge was washed with 70:30 MeCN:H2O (50 mL) to obtain the fraction containing the organic compounds, and washed with THF (30 mL) to obtain the fraction containing the fluorous compounds. The fluorous fraction was dried with Na2SO4 and the solvent was evaporated in vacuo to afford the azido β-peptide.

General procedure 5: hydrogenation

In a GreenHouse Classic Parallel Synthesizer, a solution of each azido-tripeptide (8 mg) in tert-butanol (2 mL) was loaded to each test tube. Pd(OH)2/C (2 mg, 25 w%) was added to each solution. The apparatus was evacuated and then filled with hydrogen gas by a balloon. With stirring on, all reactions were done in 24 h according to TLC. The solvent was removed in vacuo using a vacuum centrifuge. The 24 reaction mixtures were directly loaded onto a preconditioned SPE cartridge plate, with each cartridge packed with FluoroFlash silica gel (3 g).14 The cartridges were first eluted with 70:30 MeCN:H2O (2 × 5 mL). The solvent was removed in vacuo by vacuum centrifuge to afford the β-tripeptides. The cartridges were washed with THF (3 × 5 mL) to remove the FPMB residue and they were then ready for reuse.

Compound Characterization

Complete characterization data, including copies of NMR spectra and HPLC traces, are provided in the Supplementary Material.

Supplementary Material

01

Acknowledgments

We thank the National Institute of General Medical Sciences of the National Institutes of Health for funding this work. We thank Mr. Xiaoqiang Shen for helpful advice on making and opening the lactones.

Footnotes

Supplementary Data Material

Contains full details of experiments and characterization (147 pages). This material is available free of charge via the Internet at http://www.sciencedirect.com.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.(a) Seebach D, Matthews JL. J Chem Soc, Chem Commun. 1997:2015–2022. [Google Scholar]; (b) Gademann K, Hintermann T, Schreiber JV. Curr Med Chem. 1999;6:905–25. [PubMed] [Google Scholar]; (c) Cheng RP, Gellman SH, DeGrado WF. Chem Rev. 2001;101:3219–3232. doi: 10.1021/cr000045i. [DOI] [PubMed] [Google Scholar]
  • 2.Recent leading references: Murray JK, Gellman SH. Org Lett. 2005;7:1517–20. doi: 10.1021/ol0501727.Murray JK, Farooqi B, Sadowsky JD, Scalf M, Freund WA, Smith LM, Chen J, Gellman SH. J Am Chem Soc. 2005;127:13271–13280. doi: 10.1021/ja052733v.Kimmerlin T, Seebach D. J Peptide Res. 2005;65:229–260. doi: 10.1111/j.1399-3011.2005.00214.x.Seebach D, Kimmerlin T, Sebesta R, Campo MA, Beck AK. Tetrahedron. 2004;60:7455–7506.Watts P, Wiles C, Haswell SJ, Pombo-Villar E. Tetrahedron. 2002;58:5427–5439.
  • 3.Nelson SG, Spencer KL, Cheung WS, Mamie SJ. Tetrahedron. 2002;58:7081–7091. [Google Scholar]
  • 4.(a) Garcia J, Urpi F, Vilarrasa J. Tetrahedron Lett. 1984;25:4841–4844. [Google Scholar]; (b) Meldal M, Juliano MA, Jansson AM. Tetrahedron Lett. 1997;38:2531–2534. [Google Scholar]
  • 5.(a) Opening of enantioenriched β-lactones: Wang Y, Tennyson RL, Romo D. Heterocycles. 2004;64:605–658.(b) Asymmetic azide conjugate addition: Horstmann TE, Guerin DJ, Miller SJ. Angew Chem Int Ed. 2000;39:3635–3638. doi: 10.1002/1521-3773(20001016)39:20<3635::aid-anie3635>3.0.co;2-y.
  • 6.Reviews of light fluorous chemistry: Curran DP. Aldrichim Acta. 2006;39:3–9.Curran DP. In: The Handbookof Fluorous Chemistry. Gladysz JA, Curran DP, Horvath IT, editors. Wiley-VCH; Weinheim: 2004. pp. 128–155.Zhang W. Chem Rev. 2004;104:2531–2556. doi: 10.1021/cr030600r.
  • 7.Overview of fluorous tagging in synthesis of peptides and other biomolecules: Zhang W. Curr Opin Drug Disc Dev. 2004;7:784–797.
  • 8.Reviews: Zhang W, Curran DP. Tetrahedron. 2006;62:11837–11865. doi: 10.1016/j.tet.2006.08.051.Curran DP. In: The Handbook of Fluorous Chemistry. Gladysz JA, Curran DP, Horvath IT, editors. Wiley-VCH; Weinheim: 2004. pp. 101–127.Curran DP. Synlett. 2001:1488–1496.
  • 9.Curran DP, Furukawa T. Org Lett. 2002;4:2233–2235. doi: 10.1021/ol026084t.Zhang W. Review of fluorous protecting groups. In: The Handbook of Fluorous Chemistry. Gladysz JA, Curran DP, Horvath IT, editors. Wiley-VCH; Weinheim: 2004. pp. 222–235.(c) The fluorous PMB alcohol and fluorous silica products were purchased from Fluorous Technologies, Inc. DPC has an equity interest in this company.
  • 10.(a) Staudinger H, Meyer J. Helv Chim Acta. 1919;2:635–646. [Google Scholar]; (b) Leffler JE, Temple RD. J Am Chem Soc. 1967;89:5235–5246. [Google Scholar]; (c) Venturini A, Gonzalez J Org Chem. 2002;67:9088–9089. doi: 10.1021/jo026188h. [DOI] [PubMed] [Google Scholar]; (d) Chen J, Forsyth CJ. Org Lett. 2003;5:1281–1283. doi: 10.1021/ol0342148. [DOI] [PubMed] [Google Scholar]; (d) Gololobov YG. Tetrahedron. 1981;37:437–472. [Google Scholar]
  • 11.For the reverse approach with a fluorous phosphine and a non-fluorous substate, see: Lindsley CW, Zhao Z, Newton RC, Leister WH, Strauss KA. Tetrahedron Lett. 43;2002:4467–4470.
  • 12.Zhang W, Lu YM. J Comb Chem. 2006;8:890–896. doi: 10.1021/cc0601130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Curran DP, Wang X, Zhang Q. J Org Chem. 2005;70:3716–3719. doi: 10.1021/jo050116j. [DOI] [PubMed] [Google Scholar]
  • 14.Zhang W, Lu Y, Nagashima T. J Comb Chem. 2005;7:893–897. doi: 10.1021/cc050061z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES